Table 3.

Reasons for Prescribing Sertindole Treatment

	Number of patients (%)
Reasons	"Before" subgroup (n = 1,039)*	"After" subgroup (n = 393)**
Lack of efficacy of previous treatment	498 (49.0%)	222 (57.2%)
Adverse event under previous treatment	259 (25.5%)	73 (18.8%)
Patient desire to continue	146 (14.4%)	41 (10.6%)
Non compliance to previous treatment	74 (7.2%)	27 (7.0%)
Other reasons	40 (3.9%)	25 (6.4%)
Total	1,017 (100.0%)	388 (100.0%)

* This group consisted of patients who started taking sertindole before the market suspension and who continued to take it during the suspension; information was missing for 22 patients

** This group consisted of patients who started taking sertindole during the market suspension; information was missing for 5 patients